Sandy Kotiah, M.D.

Sandy Kotiah, M.D.

Sandy D. Kotiah, M.D., a Board Certified medical oncologist, serves as the Director of The Neuroendocrine Tumor Center at Mercy and is a member of Medical Oncology and Hematology at Mercy in Baltimore, Maryland. Dr. Kotiah leads a multidisciplinary team of specialty doctors focused on providing some of the best treatment options for rare neuroendocrine diseases. Dr. Kotiah’s compassionate and caring nature as well as her exceptional clinical knowledge and dedication to searching for answers to complicated cancer diagnoses makes her a sought after Medical Oncologist and Hematologist in the Baltimore region. 

Specialized Focus and Treatment of Cancer Conditions

Dr. Sandy Kotiah works with patients to diagnose, evaluate and treat a variety of cancers and blood diseases including neuroendocrine tumors, blood cancers (such as multiple myeloma), breast cancer, colon and rectal cancer, lung cancer and lymphoma. In particular, Dr. Kotiah has specialized training and certification in performing bone marrow biopsies and administering intrathecal chemotherapy. She visits her patients during chemotherapy treatments to provide support and comfort and keeps her patients’ primary care doctors informed of their treatment progress.

Leadership in Rare Neuroendocrine Tumor Treatment

Mercy Medical Center is proud to have one of the few Neuroendocrine Tumor Centers in the nation. As Director, Dr. Sandy Kotiah works in collaboration with a specialized team of physicians committed to diagnosing and treating neuroendocrine tumors. The team collaborates to develop patient-specific treatment options and management plans. Dr. Kotiah and the neuroendocrine team help patients understand their conditions and guide them and their family members through the entire process. 

A lecturer and researcher on neuroendocrine tumors as well as a physician, Dr. Kotiah helps patients fully understand their diagnosis and hosts quarterly meetings for patients and their families to present information about neuroendocrine tumors and how to cope with a neuroendocrine diagnosis. She participates in various clinical trials and is actively involved in research. 

Awards and Recognition

Dr. Sandy Kotiah, who is fluent in both French and Creole, has been recognized with a “Patients' Choice Award.” The award is presented on behalf of patient feedback and in recognition of Dr. Kotiah’s compassionate care and bedside manner.

She also has been named a "Top Doctor" in Medical Oncology by Baltimore magazine, as well as Castle Connolly Medical, Ltd.

Education & Fellowships

• Fellowship  – Thomas Jefferson University Hospital, Philadelphia
• Residency – Thomas Jefferson University Hospital, Philadelphia
• Medical Degree – University of Buffalo School of Medicine, Buffalo, New York
  
  

Associations and Memberships

• American Society of Clinical Oncology
• American Society of Hematology
• American Medical Association
• North American Neuroendocrine Tumor Society (NANETS)